Literature DB >> 30745493

Dietary Inflammatory Index Positively Associated With High-Sensitivity C-Reactive Protein Level in Japanese From NIPPON DATA2010.

Yunqing Yang1, Atsushi Hozawa1,2, Mana Kogure1,2, Akira Narita1,2, Takumi Hirata1,2, Tomohiro Nakamura1,2, Naho Tsuchiya1,2, Naoki Nakaya1,2, Toshiharu Ninomiya3, Nagako Okuda4, Aya Kadota5,6, Takayoshi Ohkubo7, Tomonori Okamura8, Hirotsugu Ueshima5,6, Akira Okayama9, Katsuyuki Miura5,6.   

Abstract

BACKGROUND: It has been reported that chronic inflammation may play an important role in the pathogenesis of several serious diseases and could be modulated by diet. Recently, the Dietary Inflammatory Index (DII®) was developed to assess the inflammatory potential of the overall diet. The DII has been reported as relevant to various diseases but has not been validated in Japanese. Thus, in the present study, we analyzed the relationship between DII scores and high-sensitivity C-reactive protein (hs-CRP) levels in a Japanese population.
METHODS: Data of the National Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged 2010 (NIPPON DATA2010), which contained 2,898 participants aged 20 years or older from the National Health and Nutrition Survey of Japan (NHNS2010), were analyzed. Nutrient intakes derived from 1-day semi-weighing dietary records were used to calculate DII scores. Energy was adjusted using the residual method. Levels of hs-CRP were evaluated using nephelometric immunoassay. Multiple linear regression analyses were performed.
RESULTS: After adjusting for age, sex, smoking status, BMI, and physical activity, a significant association was observed between DII scores and log(CRP+1) (standard regression coefficient = 0.05, P < 0.01). Although it was not statistically significant, the positive association was consistently observed in almost all age-sex subgroups and the non-smoker subgroup.
CONCLUSIONS: The current study confirmed that DII score was positively associated with hs-CRP in Japanese.

Entities:  

Keywords:  CRP; Japanese; Japanese diet; dietary inflammatory index; inflammation

Year:  2019        PMID: 30745493      PMCID: PMC6949183          DOI: 10.2188/jea.JE20180156

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


INTRODUCTION

Inflammation constitutes the body’s protective response to injury or infection and is generally beneficial to the body.[1] However, when the inflammatory response proceeds disorderedly, acute inflammation can progress to chronic inflammation,[2] which features sustained increased level of inflammatory cytokines, such as Interleukin 6 (IL-6), Tumor Necrosis Factor-α (TNF-α), and C-reactive protein (CRP). It has been reported that inflammation response and metabolic regulation are highly integrated and interdependent.[3] Chronic inflammation, which is the dysfunction of the inflammatory response, can lead to a variety of diseases, such as diabetes, cancer, and depression, which seriously threatens health.[4]–[6] Growing evidence has shown that diet plays a key role in the regulation of chronic inflammation. For example, the Mediterranean diet, which is rich in fish, monounsaturated fats from olive oil, fruits, vegetables, whole grains, and involves moderate alcohol consumption, has been shown to be associated with lower levels of inflammatory markers.[7] In contrast, the Western diet, also known as the “obesogenic” diet, characterized by a high intake of saturated fat from red meat and dairy products, refined grains, and sugar, may promote metabolic disorders through pro-inflammatory mechanisms.[8] Recently, a literature-derived, population-based diet quality assessing tool—the Dietary Inflammatory Index (DII®)—was developed for evaluating the inflammatory potential of one’s overall diet.[9] The DII has been construct validated in American, European, Asian, and Australia individuals with inflammatory markers including CRP, IL-6, and TNF-α,[10]–[14] and was reported to have associations with a variety of diseases. A recent published meta-analysis reported that there were consistent and significant positive associations between higher DII scores and cancer incidence and mortality across cancer types.[15] Another review of cardiovascular diseases concluded that the DII was a useful tool for appraising the inflammatory potential of diet and for helping to explore the mechanisms between diet, inflammation, and cardio-metabolic diseases.[16] A few relevant studies have been carried out in Asia; one of them was conducted in Japan.[17] Japanese have enjoyed the world’s longest average life expectancy since 1985,[18] which may partially be due to the Japanese traditional diet, Washoku, which was included in the United Nations Educational, Scientific and Cultural Organization list of Intangible Cultural Heritage in 2013.[19],[20] The Japanese diet incorporates high consumption of fish and soybean products and low consumption of animal fat and meat and has been reported as having a negative association with cardiovascular disease risks,[20] psychological distress,[21] and cancer.[22] Whether the DII scores of the Japanese population that consumed a predominantly Japanese diet are applicable to epidemiological studies remains unclear. For this purpose, it was necessary to validate the DII using a Japanese database so that more researches could be conducted. Therefore, we evaluated the association between DII scores and hs-CRP levels in Japanese using data from National Integrated Project for Prospective Observation of Non-Communicable Disease and Its Trends in the Aged 2010 (NIPPON DATA2010).[23]–[25]

MATERIAL AND METHODS

Study population

NIPPON DATA2010 was a nationally representative cohort study based on the National Health and Nutrition Survey of Japan in 2010 (NHNS2010),[26] which used validated high-accuracy semi-weighing dietary records. The details of NHNS2010 and NIPPON DATA2010 have been described elsewhere.[26],[27] Briefly, 8,815 residents from 300 randomly selected survey areas throughout Japan participated in NHNS2010. Among them, 7,229 participants were aged 20 years or older, and 3,873 of the 7,229 completed the blood tests. Finally, 2,898 participants (1,239 men and 1,659 women, response rate: 74.6%) from the NHNS2010 agreed to be involved in the baseline survey of NIPPON DATA2010, which included electrocardiography, urinalysis, and questionnaires and was conducted in November 2010,[25],[27] and were subsequently recruited to the current study. Among the 2,898 participants, 7 participants could not be included due to unusable data, and 94 were excluded for the following reasons: incomplete data of food and nutrient intake (n = 51), extreme calorie intake <500 kcal/d (n = 2) or >5,000 kcal/d (n = 1)[28]; and missing data on weight or height (n = 2), physical activity (n = 4), or smoking status (n = 8). Considering the extremely low level of hs-CRP in Japanese, which is approximately one third of the median value in Caucasians,[29],[30] and the findings of one study conducted in six Asian cities suggesting that the reference CRP interval of Japanese was from 0.04 mg/L to 2.26 mg/L,[31] we excluded participants with a CRP level >3 mg/L from the analyses (n = 251). Finally, a total of 2,572 participants were included in the analysis (Figure 1).
Figure 1.

Flow diagram of study population. Participants were excluded for the following reasons: 1) younger than 20 years old or absence of blood examination; 2) without informed consent; 3) data could not be utilized; 4) having incomplete data on food and nutrient intake; 5) calorie intake less than 500 kcal/d or more than 5,000 kcal/d; 6) high-sensitivity C-reactive protein level >3 mg/L; 7) physical activity unknown; 8) smoking status unknown; 9) BMI could not be calculated.

The Institutional Review Board of Shiga University of Medical Science approved this study (No. 22-29, 2010).

Dietary intake and DII

Data on dietary intake were collected from 1-day semi-weighing household dietary records. Participants were asked to weigh and record all portions of foods, beverages, and nutrient supplements consumed by each household member in a whole day. In addition, participants were asked to carry out the dietary records on a normal day for representing dietary habits. Trained dietitians visited the participants’ homes to assist with and confirm the dietary records. Nutrient intakes were estimated using the Standard Tables of Food Composition in Japan, Fifth Revised and Enlarged Edition.[26],[32] The DII was developed as a diet quality-assessing tool based on the inflammatory potential of the overall diet. Forty-five food or nutrient parameters were identified by their effects on six inflammatory markers (IL-1β, IL-4, IL-6, IL-10, TNF-α, and CRP), and a global standard database was created for comparing DII scores in diverse populations. A more detailed description of the DII has been provided elsewhere.[9] Briefly, the DII provided an overall inflammatory effect score, a global daily mean intake, and a standard deviation for each food parameter. First, every nutrient intake was transformed to a Z-score using the standard values described above. To minimize the ‘right skewing,’ each Z-score was converted to a percentile value, which was then doubled, and 1 was subtracted from the doubled percentile value. Next, the centered value was multiplied by its respective overall inflammatory effect score. Finally, all parameter-specific DII scores were summed to achieve the overall DII score for each subject. In the current study, 26 food or nutrient parameters, including vitamin B12, carbohydrate, cholesterol, total fat, iron (Fe), protein, saturated fat, magnesium (Mg), zinc (Zn), vitamin A, β-carotene, vitamin D, vitamin E, thiamine, riboflavin, niacin, vitamin B6, folic acid, vitamin C, monounsaturated fatty acid (MUFA), polyunsaturated fatty acid (PUFA), fiber, n-3 fatty acid, n-6 fatty acid, alcohol, and onion could be used to calculate DII scores (eTable 1). Among these, alcohol consumption was calculated from data of lifestyle surveys, and the others were derived from dietary records. Energy adjustment was performed using the residual method.[33]

C-reactive protein

Fasting blood samples were drawn from all participates in November 2010. Levels of hs-CRP were measured using nephelometric immunoassay at a commercial laboratory (SRL, Tokyo, Japan).

Covariates

Anthropometric measurements were performed by trained staff. Height and weight were measured and used to calculate the BMI as the ratio of weight to the square of height. Lifestyle surveys, including information on smoking (current, former, or never smoker), physical activity (Metabolic equivalents [METs]/d) and antilipidemic agent use (user or non-user), were conducted by public health nurses using a standard questionnaire.[26] Information on socioeconomic status, such as marital status (married or unmarried), education (junior high school and below, high school, or university and above), and equivalent household expenditure was collected from the self-administered questionnaires. (1 Yen = 0.008989 United States dollar as of January 2018)

Statistical analysis

The characteristics of participants and food intakes across the DII quartiles were compared using chi-square test for categorical variables and ANOVA for continuous variables. Levels of hs-CRP were log-transformed due to its right-skewed distribution. To determine the association between DII scores and log-transformed (hs-CRP+1) [log(CRP+1)], Spearman’s correlation and multiple linear regression were analyzed. As potential confounders, age, sex, smoking status, BMI, and physical activity were adjusted. Moreover, analyses were further stratified by sex (men and women), age group (aged <45, 45–54, 55–64, 65–74, and ≥75 years) and smoking status (never-smoker, former-smoker, and current smoker). Additionally, we analyzed other factors as covariates, including economic status, marital status, education, and antilipidemic agent use. All statistical analyses were performed using Statistical Analysis Systems statistical software package version 9.4 (SAS Institute, Cary, NC, USA).

RESULTS

The mean DII score of the study participants was 0.82, with a SD of 1.75. Table 1 showed the characteristics of the study participants across DII score quartiles: −5.04 ≤ Q1 < −0.38; −0.38 ≤ Q2 < 0.91; 0.91 ≤ Q3 < 2.18; 2.18 ≤ Q4 ≤ 4.94. The proportion of women decreased with DII score quartiles, indicating that, compared with men, women consumed a more anti-inflammatory diet. Participants in Q4, the most pro-inflammatory diet-consuming group, were more likely to be younger, antilipidemic agent non-user, underweight or overweight, smokers, with higher physical activity, lower equivalent household expenditure, and more likely to be single than participants in other quartiles.
Table 1.

Characteristics across quartiles of Dietary Inflammatory Index (DII®) scores

 DII quartilesa

 Q1 Q2 Q3 Q4  
Characteristicsn%n%n%n%P-value
Median DII score−1.38 0.33 1.55 2.85 <0.01
Sex         
 Men23937.225339.427442.632049.8<0.01
 Women40462.839060.736957.432350.2 
Age, years, mean (SD)64.4 (12.3)61.3 (14.8)56.1 (16.5)52.3 (16.5)<0.01
BMI, kg/m2         
 <18.5385.9426.5325.0558.60.03
 18.5 to <25.044869.744168.643066.940062.2 
 ≥25.015724.416024.918128.218829.2 
Smoking         
 Current smoker517.97111.011017.116225.2<0.01
 Former smoker11117.313120.412419.313220.5 
 Never-smoker48174.844168.640963.634954.3 
Physical activity, METs/d37.3 (8.0)37.0 (7.9)37.5 (9.0)38.6 (9.6)<0.01
Antilipidemic agentb         
 User12619.611517.98713.6639.8<0.01
 Non-user51780.452882.155586.558090.2 
Marital statusb         
 Married51380.051179.648375.445671.6<0.01
 Single12820.013120.415824.718128.4 
Educationb         
 Middle or lower16726.016225.214522.614222.10.47
 High school27943.426741.529646.128844.9 
 University or higher19730.621433.320131.321233.0 
Equivalent household expenditure, million Yen/month, mean (SD)b
 16. (10.1)15.7 (14.5)14.6 (12.6)14.3 (18.7)<0.01

BMI, body mass index; METs, metabolic equivalents; SD, standard deviation.

aDII quartiles: −5.04 ≤ Q1 < −0.38; −0.38 ≤ Q2 < 0.91; 0.91 ≤ Q3 < 2.18; 2.18 ≤ Q4 ≤ 4.94.

bSample size: antilipidemic agent use = 2,571; marital status = 2,561; education = 2,570; equivalent household expenditure = 2,380.

BMI, body mass index; METs, metabolic equivalents; SD, standard deviation. aDII quartiles: −5.04 ≤ Q1 < −0.38; −0.38 ≤ Q2 < 0.91; 0.91 ≤ Q3 < 2.18; 2.18 ≤ Q4 ≤ 4.94. bSample size: antilipidemic agent use = 2,571; marital status = 2,561; education = 2,570; equivalent household expenditure = 2,380. Comparing the food intakes distribution across the DII quartiles, we found certain food intakes were related to the decrease or increase of DII scores. With the increase in cereal, meat, fat, and oil intake, the DII score increased. On the other hand, potato, bean, nut and seed, vegetable, fruit, mushroom, seaweed, seafood, milk, and nutrients supplementary food showed an effect of lowering DII score in the current study (Table 2).
Table 2.

Food intakes across quartiles of Dietary Inflammatory Index (DII®) scoresa

Food item (g)Q1SDQ2SDQ3SDQ4SD
Cereal393.28145.20425.79156.73449.87167.15507.25191.50
Potato80.3284.2261.0068.1352.0562.9341.7353.20
Sugar and Sweeteners7.898.657.317.886.968.817.7711.46
Bean99.1890.0875.1481.2353.3964.7241.9259.39
Nut and seed4.4510.232.9810.011.786.841.245.06
Vegetable459.00179.31329.42145.18258.89134.71179.58111.20
Fruit190.88150.37138.68129.3198.97113.6661.1393.60
Mushrooms28.8335.2422.0529.4815.6824.4411.5720.95
Seaweeds19.1331.8311.9420.5111.3120.838.0416.82
Seafood107.9376.2989.6371.3979.9177.6457.2666.25
Meat63.2057.0368.3859.6978.2867.2892.1280.79
Egg33.6930.6637.9932.3636.6534.3934.7333.49
Milk118.36122.92111.36127.04100.23132.2693.13125.75
Fat and oil8.928.448.958.4410.319.7310.588.83
Confectionery19.8634.2426.3543.8926.0444.6036.3656.19
Preferred beverage766.11469.28720.00471.81702.66511.27720.13522.49
Seasoning and Spice99.87146.7892.9681.5084.5978.2191.8895.38
Nutrients supplementary food19.0358.9918.3961.3518.2269.1610.6362.21

SD, standard deviation.

aDII quartiles: −5.04 ≤ Q1 < −0.38; −0.38 ≤ Q2 < 0.91; 0.91 ≤ Q3 < 2.18; 2.18 ≤ Q4 ≤ 4.94.

SD, standard deviation. aDII quartiles: −5.04 ≤ Q1 < −0.38; −0.38 ≤ Q2 < 0.91; 0.91 ≤ Q3 < 2.18; 2.18 ≤ Q4 ≤ 4.94. We did not observe significant correlation between DII scores and log(CRP+1) when analyzing in crude (r = 0.02, P = 0.41). After adjusting for age, sex, smoking status, BMI, and physical activity, a significant relationship was observed between DII scores and log(CRP+1) (standard regression coefficient of total = 0.05, P < 0.01) (Table 3). The standardized regression coefficient of the covariates was reduced in the order of BMI (0.33), age (0.14), current smoking (0.06), physical activity (0.06), and DII score (0.05).
Table 3.

Multiple linear regression analysis between log-transformed hs-CRP and other variables, stratified by sexa

 Men n = 1,086cWomen n = 1,486cTotal n = 2,572d
VariableStandardized ββ95% CIPStandardized ββ95% CIPStandardized ββ95% CIP
DII scoreb0.050.01−0.0030.020.140.060.010.0010.020.020.050.010.0030.02<0.01
Ageb0.130.0030.0010.004<0.010.130.0020.0020.003<0.010.140.0030.0020.003<0.01
BMIb0.270.030.020.03<0.010.370.030.030.04<0.010.330.030.0260.032<0.01
Sex (ref. women)          0.0070.004−0.020.030.76
Smoking (ref. never-smokers)              
Former smokers0.030.02−0.020.060.300.040.05−0.010.110.070.030.02−0.010.050.17
Current smokers0.100.070.030.12<0.01−0.001−0.001−0.060.060.970.060.050.020.09<0.01
Physical activityb−0.06−0.002−0.003−0.000010.06−0.06−0.003−0.005−0.0010.01−0.06−0.002−0.003−0.001<0.01

BMI, body mass index; CI, confidence interval; hs-CRP, highly sensitive C-reactive protein.

ahs-CRP, high-sensitivity C-reactive protein; DII, Dietary inflammatory index; energy was adjusted by residual method.

bContinuous variable.

cAdjusted for age, BMI, smoking status, and physical activity.

dAdjusted for age, BMI, sex, smoking status, and physical activity.

BMI, body mass index; CI, confidence interval; hs-CRP, highly sensitive C-reactive protein. ahs-CRP, high-sensitivity C-reactive protein; DII, Dietary inflammatory index; energy was adjusted by residual method. bContinuous variable. cAdjusted for age, BMI, smoking status, and physical activity. dAdjusted for age, BMI, sex, smoking status, and physical activity. Furthermore, the results of multiple linear regression analysis stratified by sex and age group are shown in Table 4. Consistent positive associations were observed both in men (although it was not statistically significant, standardized regression coefficient = 0.05, P = 0.14) and women (standardized regression coefficient = 0.06, P = 0.02). All age groups displayed a positive association, (standardized regression coefficient<45 = 0.05, standardized regression coefficient45–54 = 0.03, standardized regression coefficient55–64 = 0.03, standardized regression coefficient65–74 = 0.05, standardized regression coefficient≥75 = 0.10). The highest standardized regression coefficient between the DII and log(CRP+1) was observed in the ≥75 years age group. As regards age-sex combined subgroups, all subgroups except for men aged <45 years and women aged 55–64 years showed positive relationships between DII scores and log(CRP+1).
Table 4.

Multiple linear regression analysis between log-transformed hs-CRP and Dietary Inflammatory Index (DII®) scores, stratified by age and sex

  Men  Women  Total 
Age, yearsNstandardized βPaNstandardized βPaNstandardized βPb
<45212−0.050.423610.110.025730.050.21
45–541350.050.532020.020.753370.030.51
55–642550.100.12336−0.040.505910.030.43
65–743090.010.913690.080.116780.050.19
≥751750.040.612180.140.043930.100.05
Total1,0860.050.141,4860.060.022,5720.05<0.01

hs-CRP, high-sensitivity C-reactive protein.

aAdjusted for age, smoking status, BMI, and physical activity.

bAdjusted for age, sex, smoking status, BMI, and physical activity.

hs-CRP, high-sensitivity C-reactive protein. aAdjusted for age, smoking status, BMI, and physical activity. bAdjusted for age, sex, smoking status, BMI, and physical activity. Additionally, we analyzed other factors as covariates, including economic status, marital status, education, and antilipidemic agent use, gaining unchanging result (standardized regression coefficient = 0.06, P < 0.01). Further, the positive association was observed in the never-smoker (standardized regression coefficient = 0.06, P = 0.01, n = 1,680) and former-smoker (standardized regression coefficient = 0.08, P = 0.07, n = 498) subgroup, but not in the current-smoker subgroup (standardized regression coefficient = −0.02, P = 0.71, n = 394), when analysis was stratified by smoking status.

DISCUSSION

In our cross-sectional study, we observed a positive association between DII scores and hs-CRP levels in participants of NIPPON DATA2010. The findings were consistent across almost all age-sex subgroups. The results suggested that the DII was applicable to the Japanese population.

Previous studies on DII scores and CRP levels

To the best of our knowledge, there have been 21 previous studies that investigated the association between DII scores and CRP levels (Table 5). Fourteen of them concurred with our conclusion that the DII scores positively associated with CRP levels. Of the other seven studies, five concluded that the DII score was associated with other inflammatory markers. To our best knowledge, ours is the first written report to correctly validate the DII in Japanese with CRP.
Table 5.

Previous research on association between Dietary Inflammatory Index (DII®) and CRP

AuthorYearCountry or raceNumber of food parametersInflammatory markersRisk estimate
Vahid F[47]2018Iran31TNF-αaIL-4aIL-10aIL-1βaCRPaIL-6a Partial correlation coefficient
CRP (mg/L) 0.328 P > 0.001
TNF-α (pg/ml) 0.373 P > 0.001
IL-6 (pg/ml) 0.337 P > 0.001
IL-1β (pg/ml) 0.326 P > 0.001
IL-4 (pg/ml) 0.046 P = 0.544
IL-10 (pg/ml) −0.333 P > 0.001

Phillips CM[48]2018Ireland26Inflammatory scoreC3aCRPIL-6TNF-αAdiponectin LeptinResistinWBCaNeutrophilsLymphocytesMonocytesEosinophilsBasophilsNeutrophil to lymphocyte ratioMean of < Median E-DII vs > Median E-DIIInflammatory score 7.74 ± 0.12 vs 8.29 ± 0.10 P < 0.001C3 (mg/dL) 134.31 ± 0.78 vs 136.90 ± 0.76 P = 0.04CRP (mg/L) 2.19 ± 0.12 vs 2.45 ± 0.11 P = 0.03IL-6 (pg/mL) 2.72 ± 0.14 vs 3.02 ± 0.15 P < 0.001TNF-α (pg/mL) 6.23 ± 0.08 vs 6.51 ± 0.09 P = 0.001Adiponectin (ng/mL) 6.05 ± 0.13 vs 5.41 ± 0.13 P < 0.001Leptin (ng/mL) 2.85 ± 0.12 vs 2.78 ± 0.10 P = 0.11Resistin (ng/mL) 5.64 ± 0.10 vs 5.78 ± 0.11 P = 0.50WBC (109/L) 5.85 ± 0.07 vs 6.14 ± 0.06 P = 0.001Neutrophils (109/L) 3.23 ± 0.04 vs 3.48 ± 0.04 P = <0.001Lymphocytes (109/L) 1.83 ± 0.02 vs 1.86 ± 0.03 P = 0.37Monocytes (109/L) 0.51 ± 0.005 vs 0.54 ± 0.01 P < 0.001Eosinophils (109/L) 0.20 ± 0.004 vs 0.21 ± 0.005 P = 0.06Basophils (109/L) 0.031 ± 0.001 vs 0.033 ± 0.001 P = 0.03Neutrophil to lymphocyte ratio 1.89 ± 0.03 vs 2.04 ± 0.03 P < 0.001

Shivappa N[49]2018USA26CRPOR (95%CI)DII continuous (age adjusted) 1.13 (1.07, 1.20)DII continuous (multivariable) 1.12 (1.05, 1.19)

Shivappa N[45]2018GermanyNot foundCRPr = 0.12

Farhangi MA[50]2018Iran28CRPIL-6Beta estimate (95%CI) for the associationQ4vsQ1 Men 0.97 (0.89, 1.06)​   Women 0.93 (0.67, 1.30)

Almeida-de-Souza J[51]2017Portugal31CRPIL-6C3C4aOverall scoreOR (95%CI)T3vsT1 CRPa 2.33 (0.88, 6.20)​   IL-6 3.38 (1.24, 9.20)​   C3a 1.71 (0.63, 4.66)​   C4a 3.12 (1.21, 8.10)​   Overall 5.61 (2.00, 15.78)

Tabung FK[52]2017USA38CRPIL-6TNFαR2aAdiponectinPercentage change (95%CI)Q5vsQ1 NHS-IIa: CRPa +49% (+25%, +77%)​       IL-6 +21% (+9%, +33%)​       TNFαR2 +4% (+1%, +8%)​       Adiponectin −10% (−10%, −4%)Q5vsQ1 HPFSa: CRPa +29% (+15%, +44%)​       IL-6 +24% (+12%, +38%)​       TNFαR2 +5% (+1%, +8%)​       Adiponectin −4% (−9%, +2%)

Wirth MD[11]2017AfricanAmericans31CRPIL-6Percentile regression (95%CI)CRPa β 0.75: 3.95 (1.71, 6.19)​  β 0.90: 6.83 (1.11, 12.55)

Vahid F[13]2017Iran31CRPIL-6Beta estimates (95%CI)CRPa 0.04 (−0.09, 0.18)IL-6 0.16 (0.02, 0.30)

Julia C[53]2017France36CRPOR (95%CI)T3vsT1 1.32 (0.89, 1.95)

Shivappa N[54]2017European25CRPTNF-αIL-6, 1,2,4,10, IFN-γasICAMasVCAMaBeta estimates (95%CI)T3vsT1 CRPa 0.09 (−0.18, 0.36)​   TNF-α 0.13 (0.007, 0.26)​   IL-6 0.09 (−0.22, 0.40)​   IL-1 0.30 (0.02, 0.58)​   IL-2 0.42 (0.04, 0.79)​   IL-4 0.17 (−0.25, 0.59)​   IL-10 0.09 (−0.17, 0.35)​   INF-γ 0.58 (0.09, 1.06)​   ICAMa 0.02 (−0.08, 0.11)​   VCAMa 0.07 (0.01, 0.13)

Shivappa N[55]2017USA27CRPOR (95%CI)Q4vsQ1 1.53 (1.20, 1.95)

Bodén S[56]2017Sweden30CRPIL-6Beta coefficients (95%CI)Q4vsQ1 CRPa 0.41 (0.16, 0.67)​   IL-6 0.26 (0.06, 0.46)

Kizil M[57]2016Turkey25CRPr = 0.35

Sarbattama Sen[58]2016USA28CRPWBCBeta coefficients (95%CI)CRPa Continuous 0.08 (0.02, 0.14)​  Q4vsQ1 0.25 (−0.01, 0.50)WBCa Continuous −0.03 (−0.11, 0.05)​  Q4vsQ1 −0.14 (−0.45, 0.17)

Akbaraly T[37]2016UK27CRPIL-6CRPa T1 −0.13 ± 1.3​  T2 0.02 ± 1.3​  T3 0.03 ± 1.3IL-6 T1 −0.12 ± 1.3​  T2 0.002 ± 1.3​  T3 0.04 ± 1.3

Tabung FK[12]2015USA32IL-6CRPTNFα-R2Overall scoreBeta coefficients (95%CI)Q5vsQ1 IL-6 1.26 (1.15, 1.38)​   CRPa 1.07 (0.95, 1.2)​   TNFα-R2 81.43 (19.15, 143.71)​   Overall 0.26 (0.12, 0.40)OR Q5vsQ1 (95%CI)CRPa NSAIDsa non-user 1.67 (1.09, 2.55)​  NSAIDsa user 0.99 (0.65, 1.52)

Shivappa N[10]2015Belgians17CRPLeucocyte count FibrinogenHomocysteineIL-6OR (95%CI)CRPa 1.03 (0.86, 1.17)IL-6 1.19 (1.04, 1.36)Homocysteine 1.56 (1.25, 1.94)Fibrinogen 1.08 (0.78, 1.48)

Alkerwi A[59]2014Luxembourg24CRPP for trend = 0.39

Wirth MD[60]2014USANot foundCRPIL-6TNF-αOR (95%CI)Q4vQ1 1.57 (0.85, 2.88)

Shivappa N[34]2013USA44 (24-hour dietary recalls)28 (7-day dietary recalls)CRPOR (95%CI)T3vsT1 24 hour dietary recalls: 1.47 (1.03, 2.12)​   7-day dietary recall: 1.61 (1.15, 2.27)

C3, complement C3; C4, complement C4; CRP, C-reactive protein; DII, Dietary inflammatory index; HPFS, Health Professionals Follow-Up Study; IL, Interleukin; NHS-II, Nurses’ Health Study II; NSAIDs, non-steroidal anti-inflammatory drugs; sICAM, soluble intercellular cell adhesion molecule; sVCAM, soluble vascular cell adhesion molecule; TNF-α, Tumor Necrosis Factor-α; TNF-αR2, Tumor Necrosis Factor-α Receptor 2; WBC, white blood cell.

C3, complement C3; C4, complement C4; CRP, C-reactive protein; DII, Dietary inflammatory index; HPFS, Health Professionals Follow-Up Study; IL, Interleukin; NHS-II, Nurses’ Health Study II; NSAIDs, non-steroidal anti-inflammatory drugs; sICAM, soluble intercellular cell adhesion molecule; sVCAM, soluble vascular cell adhesion molecule; TNF-α, Tumor Necrosis Factor-α; TNF-αR2, Tumor Necrosis Factor-α Receptor 2; WBC, white blood cell. In the current study, 18 items of 45 food parameters were unavailable for DII score calculation, which were caffeine, eugenol, garlic, ginger, saffron, selenium, trans fat, turmeric, green/black tea, flavan-3-ol, flavones, flavonols, flavonones, anthocyanidins, isoflavones, pepper, thyme/oregano, and rosemary. However, in previous studies, the number of food parameters used was between 17 and 44. Furthermore, a construct validation study using two different diet record methods, 24-hour dietary recalls and 7-day dietary recalls, reported that the reduction of available food parameters would not lead to a large drop-off in the predictive ability of DII.[34] Thus, the 26 food parameters we used might be sufficient for validation.

International comparison of DII scores

The mean DII score of this study’s participants was 0.82 (standard deviation, 1.75). The Japanese diet is characterized by lower fat intake and higher soy and fish consumption.[35] Therefore, we expected that the mean DII score in our study would be lower than that reported for western populations. However, our results did not bear out this expectation. For instance, a study on the association between the DII score and memory function using a population-based national sample of elderly Americans reported a mean DII score of −0.25 (standard error, 0.07).[36] The mean DII score of the Whitehall II study, which was carried out in the United Kingdom, was −0.03 (standard deviation, 1.3).[37] We reasoned that it may be due to the different food parameters used. Although DII score is calculated based on the global standard database, it cannot be used to compare the inflammatory potential of diets of different countries directly without using a unified set of food parameters.

Factors relevant to elevated CRP levels

The multiple linear regression analysis suggested that ageing, smoking, and being overweight were positively associated with CRP levels, while physical activity was inversely related. We could not determine the causality through the cross-sectional studies; however, it is unlikely that an increased CRP level leads to smoking. Moreover, many previous studies reported similar results that CRP levels were higher among current smokers.[38]–[40] According to our analysis, the effect of smoking on CRP levels was similar to the effect of DII scores (standardized regression coefficient = 0.06, P < 0.01). BMI and physical activity had inverse effects on CRP levels. Our results are in accordance with several previous studies. A systematic review and a reciprocal Mendelian randomization study suggested that obesity was correlated with elevated levels of CRP.[41],[42] Moreover, increasing evidence points to the negative association between physical activity and inflammatory biomarker levels.[43],[44] Given the health benefits in metabolic regulation from physical activity, we propose that, besides diet, weight control, smoking cessation, and increasing physical activity may contribute to lower CRP levels. We found a positive association between DII scores and CRP levels in almost all age-sex subgroups, but not in a few young men and women aged 55–64 years. This was likely due to that, in the current study, participants in the youngest male subgroup had the highest smoking rate (40.09% current smoker and 22.17% former smoker). According to previous researches, smoking was an important confounder due to its relatively strong inflammatory effect. The strong inflammatory effect might cover the effect bought by diet.[45] As described in the results, only the current-smoker subgroup did not show the positive association. The smaller sample size of current-smoker may be partially responsible; however, we still believed that smoking could be considered as a reason of the negative association in this subgroup of young men. Moreover, women in the 55–64 year age group were possibly in menopause, which has been confirmed to associate with increases in CRP levels.[46] The effect of menopause might modify the association between DII scores and CRP levels. Further study investigating DII scores and CRP levels in this age-sex group might be required.

Strengths and limitations

Our study has several strengths. To our best knowledge, this is the first study of the inflammatory potential of the world-renowned Japanese diet and validation of the DII among Japanese. In addition, the participants of NIPPON DATA2010 were collected from all over Japan, with a large age span, ensuring a good representation of the Japanese population. This allowed the relatively detailed analysis of the association between DII scores and CRP levels in different sex and age groups. Certain limitations should be mentioned. It was difficult to infer the temporal association between DII scores and CRP levels with the cross-sectional study design. However, it was almost impossible that participants changed their diets due to a high CRP level. Another limitation was the lack of information on anti-inflammatory medication use. The effect of diet on inflammation might partially be masked by using medicine[12] that could lead to underestimation, which might partially explain why only weak associations were observed in the current study. Future studies should stratify analysis of the association between DII and CRP by anti-inflammatory medication. In conclusion, we confirmed that a positive association between DII scores and CRP levels was observed in the Japanese population. The findings were consistent for almost all age-sex subgroups and the never-smoker subgroup.
  56 in total

Review 1.  The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review.

Authors:  Christos Kasapis; Paul D Thompson
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

2.  Comparison of mediterranean, Western and Japanese diets and some recommendations.

Authors:  Filiz Ogce; Esin Ceber; Rabia Ekti; Nazan Tuna Oran
Journal:  Asian Pac J Cancer Prev       Date:  2008 Apr-Jun

3.  Construct validation of the dietary inflammatory index among postmenopausal women.

Authors:  Fred K Tabung; Susan E Steck; Jiajia Zhang; Yunsheng Ma; Angela D Liese; Ilir Agalliu; Melanie Hingle; Lifang Hou; Thomas G Hurley; Li Jiao; Lisa W Martin; Amy E Millen; Hannah L Park; Milagros C Rosal; James M Shikany; Nitin Shivappa; Judith K Ockene; James R Hebert
Journal:  Ann Epidemiol       Date:  2015-03-19       Impact factor: 3.797

4.  Association between dietary inflammatory index, and cause-specific mortality in the MONICA/KORA Augsburg Cohort Study.

Authors:  Nitin Shivappa; Andrea Schneider; James R Hébert; Wolfgang Koenig; Annette Peters; Barbara Thorand
Journal:  Eur J Public Health       Date:  2018-02-01       Impact factor: 3.367

Review 5.  Association between dietary inflammatory index and inflammatory markers in the HELENA study.

Authors:  Nitin Shivappa; James R Hebert; Ascensión Marcos; Ligia-Esperanza Diaz; Sonia Gomez; Esther Nova; Nathalie Michels; Aline Arouca; Esther González-Gil; Gottrand Frederic; Marcela González-Gross; Manuel J Castillo; Yannis Manios; Mathilde Kersting; Marc J Gunter; Stefaan De Henauw; Kafatos Antonios; Kurt Widhalm; Denes Molnar; Luis Moreno; Inge Huybrechts
Journal:  Mol Nutr Food Res       Date:  2017-02-22       Impact factor: 5.914

6.  Association between the dietary inflammatory index (DII) and telomere length and C-reactive protein from the National Health and Nutrition Examination Survey-1999-2002.

Authors:  Nitin Shivappa; Michael D Wirth; Thomas G Hurley; James R Hébert
Journal:  Mol Nutr Food Res       Date:  2017-02-01       Impact factor: 5.914

Review 7.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

Review 8.  Postmenopausal hypertension.

Authors:  Licy L Yanes; Jane F Reckelhoff
Journal:  Am J Hypertens       Date:  2011-04-21       Impact factor: 2.689

Review 9.  C-reactive protein and cardiovascular disease in East asians: a systematic review.

Authors:  Isao Saito; Koutatsu Maruyama; Eri Eguchi
Journal:  Clin Med Insights Cardiol       Date:  2015-02-03

10.  The National Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged 2010 (NIPPON DATA2010): Objectives, Design, and Population Characteristics.

Authors:  Aya Kadota; Nagako Okuda; Takayoshi Ohkubo; Tomonori Okamura; Nobuo Nishi; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  J Epidemiol       Date:  2018       Impact factor: 3.211

View more
  4 in total

1.  "Association between dietary inflammatory index (DII) and risk of irritable bowel syndrome: a case-control study".

Authors:  Elham Eslampour; Koroush Ghanadi; Vahideh Aghamohammadi; Alireza Moayed Kazemi; Rasool Mohammadi; Farhad Vahid; Amir Abbasnezhad
Journal:  Nutr J       Date:  2021-06-28       Impact factor: 3.271

2.  Decline in independence after three years and its association with dietary patterns and IADL-related factors in community-dwelling older people: an analysis by age stage and sex.

Authors:  Sayuri Kodama; Tanji Hoshi; Sugako Kurimori
Journal:  BMC Geriatr       Date:  2021-06-26       Impact factor: 3.921

3.  Meta-analysis of the relationship between Dietary Inflammatory Index and esophageal cancer risk.

Authors:  Qiu-Jin Chen; Liang Ou; Kai Li; Feng-Rong Ou
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

4.  Influence of Nutritional Intakes in Japan and the United States on COVID-19 Infection.

Authors:  Yasuo Kagawa
Journal:  Nutrients       Date:  2022-02-01       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.